# Intravenous Norepinephrine for Orthostatic Hypotension

> **NCT01285908** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 6 (actual)

## Conditions studied

- Orthostatic Hypertension

## Interventions

- **DRUG:** Intravenous Norepinephrine Infusion

## Key facts

- **NCT ID:** NCT01285908
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2014-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01285908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01285908, "Intravenous Norepinephrine for Orthostatic Hypotension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01285908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*